跳至主要内容
临床试验/NCT01679223
NCT01679223Unknown不适用

Objective Evaluation of Collagen Deposition in AlloMaxTM Acellular Dermal Matrix in Breast Reconstruction Version 8-15-12

University of Nevada, Las Vegas1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2014年2月最近更新:
适应症

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Neoangiogenesis

研究概览

简要总结

The purpose of this study is to measure the level of AlloMax™ incorporation (cellular infiltration, collagen production, and neovascularization) in human breast reconstruction. The hypothesis is that the AlloMaxTM will have incorporation equivalent to adjacent breast capsule at the 3-4 month time point.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients (18 - 70 yrs) who require reconstructive breast surgery with AlloMaxTM implants and agree to participate will be included in this study.

排除标准

  • Patients who do not agree to be included in the study.

结局指标

主要结局

Neoangiogenesis

时间窗: 3-4 months

Measure new blood vessels in AlloMaxTM and adjacent capsule

Hydroxyproline Concentration

时间窗: 3-4 months

Hydroxyproline will be measured in the AlloMaxTM and adjacent capsule.

Collagen I and III

时间窗: 3-4 months

Measure collagen I and III in AlloMaxTM and adjacent capsule

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kayvan Taghipour-Khiabani, M.D.

Tenured Associate Professor, Head of Hand and Microsurgery

University of Nevada, Las Vegas

研究点 (1)

Loading locations...

相似试验

Incorporation of AlloMaxTM in Breast Reconstruction... | 临床试验